Chawla Lakhmir S 4
4 · REVELATION BIOSCIENCES, INC. · Filed Jan 12, 2026
Insider Transaction Report
Form 4
Chawla Lakhmir S
Director
Transactions
- Award
Common Stock
[F1]2026-01-08$0.90/sh+41,981$37,783→ 57,667 total
Holdings
- 15,686
Common Stock
Footnotes (1)
- [F1]Restricted Stock Unit under the 2021 Equity Incentive Plan. Vests quarterly over one year from the date of grant.
Signature
/s/ J.P. Galda, as attorney-in-fact for Lakhmir S Chawla|2026-01-12